SCHEMBL9167709

SCHEMBL9167709

Nc1c2c(nc3ccccc13)CCOC2

nearest known ligand 0.62

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ACHE P22303 10/20 0.62
BCHE P06276 5/20 0.62
TSHR P16473 4/20 0.62
HSD17B10 Q99714 3/20 0.62
ALDH1A1 P00352 3/20 0.62
CYP1A2 P05177 3/20 0.62
CYP2D6 P10635 2/20 0.62
KCNH2 Q12809 2/20 0.62
KDM4E B2RXH2 1/20 0.62
CACNB4 O00305 1/20 0.62
CACNA1A O00555 1/20 0.62
SLC22A2 O15244 1/20 0.62
SLC22A1 O15245 1/20 0.62
ABCC4 O15439 1/20 0.62
CACNA1G O43497 1/20 0.62
CACNG3 O60359 1/20 0.62
CACNA1F O60840 1/20 0.62
CACNA1H O95180 1/20 0.62
APP P05067 1/20 0.62
FABP1 P07148 1/20 0.62

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9737220 0.91 ACHE (0.68) ACHEBCHETSHRHSD17B10ALDH1A1
Fumaric Acid SCHEMBL9170857 0.89 TSHR (0.69) ACHEBCHETSHRHSD17B10ALDH1A1
Fumaric Acid SCHEMBL9170862 0.89 TSHR (0.69) ACHEBCHETSHRHSD17B10ALDH1A1
SCHEMBL9734944 0.89 ACHE (0.69) ACHEBCHETSHRHSD17B10ALDH1A1
SCHEMBL9735885 0.88 ACHE (0.62) ACHEBCHETSHRHSD17B10ALDH1A1
SCHEMBL9735659 0.82 ACHE (0.68) ACHEBCHETSHRHSD17B10ALDH1A1
SCHEMBL30063279 0.77 ACHE (1.00) ACHEBCHETSHRHSD17B10ALDH1A1
Tacrine SCHEMBL7714835 0.77 ACHE (1.00) ACHEBCHETSHRHSD17B10ALDH1A1
Tacrine SCHEMBL29681895 0.77 ACHE (1.00) ACHEBCHETSHRHSD17B10ALDH1A1
Tacrine SCHEMBL2828 0.77 ACHE (1.00) ACHEBCHETSHRHSD17B10ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 21 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0287977-B1 Fused heteroalkylene quinolinamines, a process and intermediates for their preparation and their use as medicaments HOECHST ROUSSEL PHARMA (US) 1994-06-29 EP claimed
US-5112830-A Cognition Activators HOECHST-ROUSSEL PHARMACEUTICALS INC. (US) 1992-05-12 US claimed
WO-1989002740-A1 4-AMINOPYRIDINE DERIVATIVES PFIZER INC. (US) 1989-04-06 WO claimed
WO-1989002739-A1 4-AMINOPYRIDINE DERIVATIVES PFIZER INC. (US) 1989-04-06 WO claimed
EP-0287977-A2 Fused heteroalkylene quinolinamines, a process and intermediates for their preparation and their use as medicaments HOECHST-ROUSSEL PHARMACEUTICALS INCORPORATED (US) 1988-10-26 EP claimed
EP-0311303-B1 4-aminopyridine derivatives PFIZER (US) 1995-05-24 EP disclosed
US-5389629-A Increase cholinergic function HOECHST-ROUSSEL PHARMACEUTICALS INCORPORATED (US) 1995-02-14 US disclosed
EP-0319429-B1 9-Acylamino-tetrahydroacridine derivatives and memory enhancing agent containing said derivative as active ingredient MITSUBISHI CHEM IND (JP) 1994-04-27 EP disclosed
US-5208330-A Cognition activators HOECHST-ROUSSEL PHARMACEUTICALS INCORPORATED (US) 1993-05-04 US disclosed
US-5206387-A Chemical intermediates for memory enhancing drugs HOECHST-ROUSSEL PHARMACEUTICALS INCORPORATED (US) 1993-04-27 US disclosed
US-5202440-A Certain 9-amino-2-(or 4)-oxa 1,2,3,4-tetrahydro- or 1,2,3,4,5,6,7,8-octahydro-acridines PFIZER INC. (US) 1993-04-13 US disclosed
US-5202440-A Certain 9-amino-2-(or 4)-oxa 1,2,3,4-tetrahydro- or 1,2,3,4,5,6,7,8-octahydro-acridines PFIZER INC. (US) 1993-04-13 US disclosed
US-5002955-A Pyrroloquinolines for enhancement of memory HOECHST-ROUSSEL PHARMACEUTICALS INC. (US) 1991-03-26 US disclosed
US-4985430-A ALZHEIMER*S DISEASE MITSUBISHI KASEI CORPORATION (JP) 1991-01-15 US disclosed
US-4843079-A ALZHEIMER*S DISEASE HOECHST-ROUSSEL PHARMACEUTICALS, INC. (US) 1989-06-27 US disclosed
EP-0319429-A2 9-Acylamino-tetrahydroacridine derivatives and memory enhancing agent containing said derivative as active ingredient MITSUBISHI KASEI CORPORATION (JP) 1989-06-07 EP disclosed
EP-0311303-A2 4-aminopyridine derivatives PFIZER INC. (US) 1989-04-12 EP disclosed
WO-1989002740-A1 4-AMINOPYRIDINE DERIVATIVES PFIZER INC. (US) 1989-04-06 WO disclosed
WO-1989002739-A1 4-AMINOPYRIDINE DERIVATIVES PFIZER INC. (US) 1989-04-06 WO disclosed
EP-0287977-A2 Fused heteroalkylene quinolinamines, a process and intermediates for their preparation and their use as medicaments HOECHST-ROUSSEL PHARMACEUTICALS INCORPORATED (US) 1988-10-26 EP disclosed